Key result
Electroconvulsive therapy was associated with a robust reduction in depressive symptoms and largely stable cognitive functioning at an average follow-up of 6.01 years.
Why the study?
Does electroconvulsive therapy (ECT) maintain long-term cognitive functioning and reduced psychiatric symptoms in patients with treatment-resistant mood disorders?
Cohort (n=34)
Does electroconvulsive therapy (ECT) maintain long-term cognitive functioning and reduced psychiatric symptoms in patients with treatment-resistant mood disorders?
For some ECT patients, memory, cognitive functioning, and decreases in depressive symptoms can remain intact and stable even several years after ECT.
Answers are grounded in this paper and cite their sources.
May support durable mood benefits without cognitive harm after ECT; leaves open need for randomized confirmation before practice change.
OBJECTIVE: Electroconvulsive therapy (ECT) is associated with positive outcomes for treatment-resistant mood disorders in the short term. However, there is limited research on long-term cognitive or psychological changes beyond 1 year after -ECT. This study evaluated long-term outcomes in cognitive functioning, psychiatric symptoms, and quality of life for individuals who had undergone ECT. METHODS: Eligible participants (N = 294) who completed a brief pre-ECT neuropsychological assessment within the last 14 years were recruited for a follow-up evaluation; a limited sample agreed to follow-up testing (n = 34). At follow-up, participants were administered cognitive measures (Repeatable Battery for the Assessment of Neuropsychological Status [RBANS], Wide Range Achievement Test-4 Word Reading, Trail Making Test, Wechsler Adult Intelligence Scale-Fourth Edition Letter Number Sequence and Digit Span, and Controlled Oral Word Association Test), along with emotional functioning measures (Beck Depression Inventory-Second Edition [BDI-II] and Beck Anxiety Inventory) and the World Health Organization Quality of Life-BREF quality of life measure. Follow-up-testing occurred on average (SD) 6.01 (3.5) years after last ECT treatment. RESULTS: At follow-up, a paired t test showed a large and robust reduction in mean BDI-II score. Scores in cognitive domains remained largely unchanged. A trend was observed for a mean reduction in RBANS visual spatial scores. Lower BDI-II scores were significantly associated with higher RBANS scores and improved quality of life. CONCLUSIONS: For some ECT patients, memory, cognitive functioning, and decreases in depressive symptoms can remain intact and stable even several years after ECT. However, the selective sampling at follow-up makes these results difficult to generalize to all post-ECT patients. Future research should examine what variables may predict stable cognitive functioning and a decline in psychiatric symptoms after ECT.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2018) conducted a cohort in treatment-resistant mood disorders (n=34). Electroconvulsive therapy (ECT) was evaluated on Long-term outcomes in cognitive functioning, psychiatric symptoms, and quality of life. Electroconvulsive therapy was associated with a robust reduction in depressive symptoms and largely stable cognitive functioning at an average follow-up of 6.01 years.
Synapse has enriched 10 related papers. Consider them for comparative context: